Plasma concentrations of osteopontin, but not thrombin-cleaved osteopontin, are associated with the presence and severity of nephropathy and coronary artery disease in patients with type 2 diabetes mellitus

<p>Abstract</p> <p>Background</p> <p>The aim of the present cross-sectional study was to assess possible associations between osteopontin (OPN), and thrombin-cleaved (N-half) OPN, and nephropathy and coronary artery disease (CAD) in patients with type 2 diabetes mellitu...

Full description

Bibliographic Details
Main Authors: Zhang Ruiyan, Zhang Qi, Wang Wei, Lu Lin, Sano Motoaki, Yan Xiaoxiang, Wang Lingjie, Chen Qiujing, Fukuda Keiichi, Shen Weifeng
Format: Article
Language:English
Published: BMC 2010-10-01
Series:Cardiovascular Diabetology
Online Access:http://www.cardiab.com/content/9/1/70
id doaj-3010501f6d9e410081b13839be8a2696
record_format Article
spelling doaj-3010501f6d9e410081b13839be8a26962020-11-25T00:33:42ZengBMCCardiovascular Diabetology1475-28402010-10-01917010.1186/1475-2840-9-70Plasma concentrations of osteopontin, but not thrombin-cleaved osteopontin, are associated with the presence and severity of nephropathy and coronary artery disease in patients with type 2 diabetes mellitusZhang RuiyanZhang QiWang WeiLu LinSano MotoakiYan XiaoxiangWang LingjieChen QiujingFukuda KeiichiShen Weifeng<p>Abstract</p> <p>Background</p> <p>The aim of the present cross-sectional study was to assess possible associations between osteopontin (OPN), and thrombin-cleaved (N-half) OPN, and nephropathy and coronary artery disease (CAD) in patients with type 2 diabetes mellitus (T2DM).</p> <p>Methods</p> <p>Plasma levels of OPN, N-half OPN, and high-sensitivity C-reactive protein (hsCRP) were determined in 301 diabetic patients with (n = 226) or without (n = 75) angiographically documented CAD (luminal diameter narrowing >50%), as well as in 75 non-diabetic controls with normal angiography. The estimated glomerular filtration rate (eGFR) was calculated in all patients.</p> <p>Results</p> <p>Plasma levels of OPN and hsCRP were significantly higher in patients with T2DM compared with controls. In addition, there was a higher occurrence of moderate renal insufficiency and lower eGFR in patients with T2DM (all <it>P </it>< 0.01). T2DM patients in whom OPN levels were greater than the median value had higher serum creatinine levels, a greater prevalence of mild or moderate renal insufficiency, a higher incidence of CAD, and lower eGFR (all <it>P </it>< 0.05) than T2DM patients in whom OPN levels were the same as or lower than the median value. However, there were no differences in these parameters when patients were stratified according to plasma N-half OPN levels. Furthermore, there was a significant correlation between OPN, but not N-half OPN, and the severity of nephropathy and CAD in diabetes. After adjustment for potential confounders and treatments, multiple linear regression analysis demonstrated an independent association between OPN, but not N-half OPN, and eGFR. Multivariate logistic regression revealed that higher OPN levels conferred a fourfold greater risk of renal insufficiency and CAD in patients with T2DM.</p> <p>Conclusions</p> <p>The results of the present study demonstrate that there is an independent association between plasma levels of OPN, but not N-half OPN, and the presence and severity of nephropathy and CAD in diabetes.</p> http://www.cardiab.com/content/9/1/70
collection DOAJ
language English
format Article
sources DOAJ
author Zhang Ruiyan
Zhang Qi
Wang Wei
Lu Lin
Sano Motoaki
Yan Xiaoxiang
Wang Lingjie
Chen Qiujing
Fukuda Keiichi
Shen Weifeng
spellingShingle Zhang Ruiyan
Zhang Qi
Wang Wei
Lu Lin
Sano Motoaki
Yan Xiaoxiang
Wang Lingjie
Chen Qiujing
Fukuda Keiichi
Shen Weifeng
Plasma concentrations of osteopontin, but not thrombin-cleaved osteopontin, are associated with the presence and severity of nephropathy and coronary artery disease in patients with type 2 diabetes mellitus
Cardiovascular Diabetology
author_facet Zhang Ruiyan
Zhang Qi
Wang Wei
Lu Lin
Sano Motoaki
Yan Xiaoxiang
Wang Lingjie
Chen Qiujing
Fukuda Keiichi
Shen Weifeng
author_sort Zhang Ruiyan
title Plasma concentrations of osteopontin, but not thrombin-cleaved osteopontin, are associated with the presence and severity of nephropathy and coronary artery disease in patients with type 2 diabetes mellitus
title_short Plasma concentrations of osteopontin, but not thrombin-cleaved osteopontin, are associated with the presence and severity of nephropathy and coronary artery disease in patients with type 2 diabetes mellitus
title_full Plasma concentrations of osteopontin, but not thrombin-cleaved osteopontin, are associated with the presence and severity of nephropathy and coronary artery disease in patients with type 2 diabetes mellitus
title_fullStr Plasma concentrations of osteopontin, but not thrombin-cleaved osteopontin, are associated with the presence and severity of nephropathy and coronary artery disease in patients with type 2 diabetes mellitus
title_full_unstemmed Plasma concentrations of osteopontin, but not thrombin-cleaved osteopontin, are associated with the presence and severity of nephropathy and coronary artery disease in patients with type 2 diabetes mellitus
title_sort plasma concentrations of osteopontin, but not thrombin-cleaved osteopontin, are associated with the presence and severity of nephropathy and coronary artery disease in patients with type 2 diabetes mellitus
publisher BMC
series Cardiovascular Diabetology
issn 1475-2840
publishDate 2010-10-01
description <p>Abstract</p> <p>Background</p> <p>The aim of the present cross-sectional study was to assess possible associations between osteopontin (OPN), and thrombin-cleaved (N-half) OPN, and nephropathy and coronary artery disease (CAD) in patients with type 2 diabetes mellitus (T2DM).</p> <p>Methods</p> <p>Plasma levels of OPN, N-half OPN, and high-sensitivity C-reactive protein (hsCRP) were determined in 301 diabetic patients with (n = 226) or without (n = 75) angiographically documented CAD (luminal diameter narrowing >50%), as well as in 75 non-diabetic controls with normal angiography. The estimated glomerular filtration rate (eGFR) was calculated in all patients.</p> <p>Results</p> <p>Plasma levels of OPN and hsCRP were significantly higher in patients with T2DM compared with controls. In addition, there was a higher occurrence of moderate renal insufficiency and lower eGFR in patients with T2DM (all <it>P </it>< 0.01). T2DM patients in whom OPN levels were greater than the median value had higher serum creatinine levels, a greater prevalence of mild or moderate renal insufficiency, a higher incidence of CAD, and lower eGFR (all <it>P </it>< 0.05) than T2DM patients in whom OPN levels were the same as or lower than the median value. However, there were no differences in these parameters when patients were stratified according to plasma N-half OPN levels. Furthermore, there was a significant correlation between OPN, but not N-half OPN, and the severity of nephropathy and CAD in diabetes. After adjustment for potential confounders and treatments, multiple linear regression analysis demonstrated an independent association between OPN, but not N-half OPN, and eGFR. Multivariate logistic regression revealed that higher OPN levels conferred a fourfold greater risk of renal insufficiency and CAD in patients with T2DM.</p> <p>Conclusions</p> <p>The results of the present study demonstrate that there is an independent association between plasma levels of OPN, but not N-half OPN, and the presence and severity of nephropathy and CAD in diabetes.</p>
url http://www.cardiab.com/content/9/1/70
work_keys_str_mv AT zhangruiyan plasmaconcentrationsofosteopontinbutnotthrombincleavedosteopontinareassociatedwiththepresenceandseverityofnephropathyandcoronaryarterydiseaseinpatientswithtype2diabetesmellitus
AT zhangqi plasmaconcentrationsofosteopontinbutnotthrombincleavedosteopontinareassociatedwiththepresenceandseverityofnephropathyandcoronaryarterydiseaseinpatientswithtype2diabetesmellitus
AT wangwei plasmaconcentrationsofosteopontinbutnotthrombincleavedosteopontinareassociatedwiththepresenceandseverityofnephropathyandcoronaryarterydiseaseinpatientswithtype2diabetesmellitus
AT lulin plasmaconcentrationsofosteopontinbutnotthrombincleavedosteopontinareassociatedwiththepresenceandseverityofnephropathyandcoronaryarterydiseaseinpatientswithtype2diabetesmellitus
AT sanomotoaki plasmaconcentrationsofosteopontinbutnotthrombincleavedosteopontinareassociatedwiththepresenceandseverityofnephropathyandcoronaryarterydiseaseinpatientswithtype2diabetesmellitus
AT yanxiaoxiang plasmaconcentrationsofosteopontinbutnotthrombincleavedosteopontinareassociatedwiththepresenceandseverityofnephropathyandcoronaryarterydiseaseinpatientswithtype2diabetesmellitus
AT wanglingjie plasmaconcentrationsofosteopontinbutnotthrombincleavedosteopontinareassociatedwiththepresenceandseverityofnephropathyandcoronaryarterydiseaseinpatientswithtype2diabetesmellitus
AT chenqiujing plasmaconcentrationsofosteopontinbutnotthrombincleavedosteopontinareassociatedwiththepresenceandseverityofnephropathyandcoronaryarterydiseaseinpatientswithtype2diabetesmellitus
AT fukudakeiichi plasmaconcentrationsofosteopontinbutnotthrombincleavedosteopontinareassociatedwiththepresenceandseverityofnephropathyandcoronaryarterydiseaseinpatientswithtype2diabetesmellitus
AT shenweifeng plasmaconcentrationsofosteopontinbutnotthrombincleavedosteopontinareassociatedwiththepresenceandseverityofnephropathyandcoronaryarterydiseaseinpatientswithtype2diabetesmellitus
_version_ 1725315350882418688